| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2379963A1 Mammalian cytokines; related reagents |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074632A1 Process for producing protein hydrolyzate |
| 02/07/2001 | EP1074624A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |
| 02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
| 02/07/2001 | EP1074562A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 02/07/2001 | EP1073763A1 Methods for transducing fusion molecules |
| 02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
| 02/07/2001 | EP1073748A2 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
| 02/07/2001 | EP1073464A1 Monoclonal antibodies with reduced immunogenicity |
| 02/07/2001 | EP1073463A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 02/07/2001 | EP0830370B1 N-1-carboxyalkyl derivatives of lsd |
| 02/07/2001 | EP0559769B1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 02/07/2001 | CN1283227A Expression cloning in filamentous fungi |
| 02/07/2001 | CN1283224A Hyaluronan synthase gene and uses thereof |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/06/2001 | US6184354 Peptides of human macrophage colony stimulating factor binding protein; for the detection of modulators of macrophage colony stimulating factor |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184342 Amino acid sequences preferential for the modulation of granulocytes migratatory response; wound healing agents |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184026 Preparing defective cells which produces preferential heterologous proteins; propagate trichoderma cells, detect cells with defective propagation phenotype, detect cells which are secreting preferential heterologous protein |
| 02/06/2001 | US6184022 Membrame matrix enzymatic protein; for use in the diagnosis and of tumors |
| 02/06/2001 | US6184020 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 02/06/2001 | US6184016 Polypeptides having prenylcysteine carboxyl methyltransferase activity or inhibiting activity |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183992 Recombinant production by constructing and using expression vector having fusion gene coding for negatively charged acidic peptide with two cysteines and positively charged basic antimicrobial peptide; minimizes effect of microbiocide |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183990 Compounds |
| 02/06/2001 | US6183989 Process for making desired polypeptides in yeast |
| 02/06/2001 | US6183986 OspA DNA and lyme disease vaccine |
| 02/06/2001 | US6183985 Transformed yeast host cell includes expression cassette coding for protein using regulatory sequences from alcohol dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase genes and expression cassette which codes for adr i |
| 02/06/2001 | US6183976 Isolated polypeptide of defined amino acid sequence having immunogenic portion of babesia microti antigen; vaccines; immunoassay detection |
| 02/06/2001 | US6183754 Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183750 Vaccines; gene expression |
| 02/06/2001 | US6183735 Immortalized retinal pigmentary epithelial cell lines and their applications |
| 02/06/2001 | CA2163032C Antibody fragments in therapy |
| 02/06/2001 | CA2125467C Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2075974C Totally synthetic affinity reagents |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
| 02/05/2001 | CA2311201A1 Ests and encoded human proteins |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007625A2 Ehrlichia canis genes and vaccines |
| 02/01/2001 | WO2001007618A1 Homeobox genes encoding proteins participating in differentiation |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007611A2 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | WO2001007607A2 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 02/01/2001 | WO2001007604A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007483A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 02/01/2001 | WO2001007481A1 Antitumor antibodies, proteins, and uses thereof |
| 02/01/2001 | WO2001007479A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | WO2001007476A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007466A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | WO2001007463A1 Trer |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007083A1 Recombinant antibody directed against human sperm antigen |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000063352A3 Human homologues of fused gene |
| 02/01/2001 | WO2000061728A3 Human elastase i |
| 02/01/2001 | WO2000061727A3 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000056357A3 Staphylococcus antigen and vaccine |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | WO2000049043A3 Human lipid-associated proteins |
| 02/01/2001 | WO2000044906A3 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI) |
| 02/01/2001 | WO2000037493A3 Type iii secretion system antigens from bordetella pertussis |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2693274A1 Peptide acceptor ligation methods |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |